129 related articles for article (PubMed ID: 20441061)
21. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study.
Kjøtrød SB; von Düring V; Carlsen SM
Hum Reprod; 2004 Jun; 19(6):1315-22. PubMed ID: 15117902
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy considerations in women with polycystic ovary syndrome.
Legro RS
Clin Obstet Gynecol; 2007 Mar; 50(1):295-304. PubMed ID: 17304043
[TBL] [Abstract][Full Text] [Related]
23. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.
Cassina M; Donà M; Di Gianantonio E; Litta P; Clementi M
Hum Reprod Update; 2014; 20(5):656-69. PubMed ID: 24861556
[TBL] [Abstract][Full Text] [Related]
24. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin.
Glueck CJ; Wang P; Goldenberg N; Sieve-Smith L
Hum Reprod; 2002 Nov; 17(11):2858-64. PubMed ID: 12407039
[TBL] [Abstract][Full Text] [Related]
25. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.
Vanky E; Salvesen KA; Heimstad R; Fougner KJ; Romundstad P; Carlsen SM
Hum Reprod; 2004 Aug; 19(8):1734-40. PubMed ID: 15178665
[TBL] [Abstract][Full Text] [Related]
26. In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study.
Diav-Citrin O; Steinmetz-Shoob S; Shechtman S; Ornoy A
Reprod Toxicol; 2018 Sep; 80():85-91. PubMed ID: 29857030
[TBL] [Abstract][Full Text] [Related]
27. Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.
Palomba S; Falbo A; Carrillo L; Villani MT; Orio F; Russo T; Di Cello A; Cappiello F; Capasso S; Tolino A; Colao A; Mastrantonio P; La Sala GB; Zullo F; Cittadini E;
Fertil Steril; 2011 Dec; 96(6):1384-1390.e4. PubMed ID: 21982727
[TBL] [Abstract][Full Text] [Related]
28. On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome - an epi-analysis.
Vanky E; DE Zegher F; Díaz M; Ibáñez L; Carlsen SM
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1460-4. PubMed ID: 23006146
[TBL] [Abstract][Full Text] [Related]
29. The effect of exercise and metformin treatment on circulating free DNA in pregnancy.
Christiansen SC; Vanky E; Klungland H; Stafne SN; Mørkved S; Salvesen KÅ; Sæther M; Carlsen SM
Placenta; 2014 Dec; 35(12):989-93. PubMed ID: 25282112
[TBL] [Abstract][Full Text] [Related]
30. Reproductive impact of polycystic ovary syndrome.
Usadi RS; Legro RS
Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):505-11. PubMed ID: 23108198
[TBL] [Abstract][Full Text] [Related]
31. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.
Palomba S; Falbo A; Russo T; Orio F; Tolino A; Zullo F
Hum Reprod; 2010 Apr; 25(4):1005-13. PubMed ID: 20106839
[TBL] [Abstract][Full Text] [Related]
32. Obese patients with polycystic ovary syndrome: evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids.
Eagleson CA; Bellows AB; Hu K; Gingrich MB; Marshall JC
J Clin Endocrinol Metab; 2003 Nov; 88(11):5158-62. PubMed ID: 14602743
[TBL] [Abstract][Full Text] [Related]
33. The Risk of Subsequent Miscarriage in Pregnant Women with Prior Polycystic Ovarian Syndrome: A Nationwide Population-Based Study.
Pan ML; Chen LR; Chen KH
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444016
[No Abstract] [Full Text] [Related]
34. Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.
Goldenberg N; Glueck C
Minerva Ginecol; 2008 Feb; 60(1):63-75. PubMed ID: 18277353
[TBL] [Abstract][Full Text] [Related]
35. The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study.
Rashidi B; Haghollahi F; Shariat M; Zayerii F
Taiwan J Obstet Gynecol; 2009 Jun; 48(2):142-7. PubMed ID: 19574176
[TBL] [Abstract][Full Text] [Related]
36. Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study.
Fulghesu AM; Romualdi D; Di Florio C; Sanna S; Tagliaferri V; Gambineri A; Tomassoni F; Minerba L; Pasquali R; Lanzone A
Hum Reprod; 2012 Oct; 27(10):3057-66. PubMed ID: 22786777
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease.
Sohrabvand F; Ansari Sh; Bagheri M
Hum Reprod; 2006 Jun; 21(6):1432-5. PubMed ID: 16478764
[TBL] [Abstract][Full Text] [Related]
38. Use of metformin in polycystic ovary syndrome.
Mathur R; Alexander CJ; Yano J; Trivax B; Azziz R
Am J Obstet Gynecol; 2008 Dec; 199(6):596-609. PubMed ID: 19084097
[TBL] [Abstract][Full Text] [Related]
39. Randomized controlled trial of different doses of metformin for ovulation induction in infertile women with polycystic ovary syndrome.
Weerakiet S; Sophonsritsuk A; Lertvikool S; Satirapot C; Leelaphiwat S; Jultanmas R
J Obstet Gynaecol Res; 2011 Sep; 37(9):1229-37. PubMed ID: 21518135
[TBL] [Abstract][Full Text] [Related]
40. Pretreatment and co-administration of oral anti-diabetic agent with clomiphene citrate or rFSH for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome.
Begum MR; Akhter S; Ehsan M; Begum MS; Khan F
J Obstet Gynaecol Res; 2013 May; 39(5):966-73. PubMed ID: 23379651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
